机构：[1]Department of Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, Guangdong, China[2]Lung Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China四川大学华西医院[3]Department of Respiratory Medicine, Wuhan Hankou Hospital, Wuhan 430010, Hubei, China[4]Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, Shandong, China
第一作者机构：[1]Department of Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, Guangdong, China
共同第一作者：
通讯作者：
通讯机构：[4]Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, Shandong, China[*1]Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, No 440 Jiyan Road, Jinan 250117, Shandong, China.
推荐引用方式(GB/T 7714)：
Kai Wang,Yang Liu,Tian Hu,et al.The treatment and outcome of a pulmonary sarcomatoid carcinoma patient infected with SARS-CoV-2.[J].LUNG CANCER.2020,146:373-375.doi:10.1016/j.lungcan.2020.06.006.
APA：
Kai Wang,Yang Liu,Tian Hu,Yumei Liu&Chao Liu.(2020).The treatment and outcome of a pulmonary sarcomatoid carcinoma patient infected with SARS-CoV-2..LUNG CANCER,146,
MLA：
Kai Wang,et al."The treatment and outcome of a pulmonary sarcomatoid carcinoma patient infected with SARS-CoV-2.".LUNG CANCER 146.(2020):373-375
